Thursday, February 24, 2022 4:17:28 PM
BACK TO THE FUTURE ?
Cancer vaccines to be at heart of 'national war' against deadly illness
Sajid Javid says jabs to potentially cure the disease over the next decade will make Britain a 'world leader' in treatment
By
Laura Donnelly,
HEALTH EDITOR
4 February 2022 • 12:01am
Vaccines to treat and potentially cure cancer will be at the heart of a “national war” on the disease over the next decade, Sajid Javid will say on Thursday.
The Health Secretary will set out a vision to make Britain a “world leader” in cancer care, amid warnings of some 50,000 missing diagnoses since the start of the pandemic.
Mr Javid will promise a 10-year Cancer Plan for England, which will use new technologies - including mRNA vaccines - to find new ways to boost survival rates.
Scientists who pioneered the jabs to protect people against Covid are examining whether similar methods can be used to train the immune system to recognise and attack cancer cells, preventing regrowth.
Mr Javid will also promise improvements in diagnosing cancer earlier, “so fewer people face the heartache of losing a loved one to this wretched disease”.
Late diagnosis has meant Britain’s cancer survival rates lagged behind many other Western nations, even before the pandemic.
Tens of thousands of people are being recruited to take part in trials of a blood test which could detect more than 50 types of cancer before symptoms appear.
In a speech at the Francis Crick Institute in London, the Health Secretary will launch an eight-week “call for evidence” to inform the 10-year plan, to be published later in the year.
“Let this be the day where we declare a national war on cancer,” he is expected to tell scientists, promising a plan which “learns the lessons from the pandemic” and applies the advances to cancer care.
The Health Secretary is expected to promise “a far-reaching look at how we want cancer care to be in 2032”, encompassing prevention, diagnosis, treatment and vaccines.
Officials are working on plans to intensify research on mRNA vaccines for cancer, bringing together learning gained through the pandemic, with expertise in cancer immunotherapy treatment.
In cancer, existing vaccines - such as the HPV jab - have largely been used to protect the body against viruses that cause cancers such as cervical disease.
But scientists have started trials of personalised vaccines which could be trained to recognise cancer cells - triggering an immune response should the disease return, which prevents its spread.
Mr Javid is expected to promise to boost the cancer workforce, in order to meet growing demand, as well as catch up with a backlog of cases which should have been diagnosed earlier.
Ministers have already promised that three in four cancers should be diagnosed at an early stage by 2028.
And health officials have promised to create 160 “faster diagnosis pathways” which aim to speed up diagnosis for cancer, and ensure fewer cases are missed.
Michelle Mitchell, Cancer Research UK’s chief executive, said: “For years, progress in cancer has been too slow – and due to the disruption of the pandemic, we now face the prospect of that progress stalling. As a country we should not be satisfied with the pace of change to date, or the fact that the burden of cancer weighs heaviest on the most deprived in the UK.
“The Secretary of State has set out a bold ambition for cancer services. We must make the most of this opportunity, going further and faster than we have before. And critically, this ambition must be backed with funding and accountability.
"It has been an incredibly difficult time for people affected by this disease. Now is the moment to work harder, and work together, for the millions of us in the UK affected by cancer.”
Front Page Newsletter
Your essential morning and evening briefing
Sign up
Related Topics
Vaccines, Cancer, NHS, Sajid Javid, Institute of Cancer Research
162
The Telegraph values your comments but kindly requests all posts are on topic, constructive and respectful. Please review our commenting policy.
Show comments
Cancer vaccines to be at heart of 'national war' against deadly illness
Sajid Javid says jabs to potentially cure the disease over the next decade will make Britain a 'world leader' in treatment
By
Laura Donnelly,
HEALTH EDITOR
4 February 2022 • 12:01am
Vaccines to treat and potentially cure cancer will be at the heart of a “national war” on the disease over the next decade, Sajid Javid will say on Thursday.
The Health Secretary will set out a vision to make Britain a “world leader” in cancer care, amid warnings of some 50,000 missing diagnoses since the start of the pandemic.
Mr Javid will promise a 10-year Cancer Plan for England, which will use new technologies - including mRNA vaccines - to find new ways to boost survival rates.
Scientists who pioneered the jabs to protect people against Covid are examining whether similar methods can be used to train the immune system to recognise and attack cancer cells, preventing regrowth.
Mr Javid will also promise improvements in diagnosing cancer earlier, “so fewer people face the heartache of losing a loved one to this wretched disease”.
Late diagnosis has meant Britain’s cancer survival rates lagged behind many other Western nations, even before the pandemic.
Tens of thousands of people are being recruited to take part in trials of a blood test which could detect more than 50 types of cancer before symptoms appear.
In a speech at the Francis Crick Institute in London, the Health Secretary will launch an eight-week “call for evidence” to inform the 10-year plan, to be published later in the year.
“Let this be the day where we declare a national war on cancer,” he is expected to tell scientists, promising a plan which “learns the lessons from the pandemic” and applies the advances to cancer care.
The Health Secretary is expected to promise “a far-reaching look at how we want cancer care to be in 2032”, encompassing prevention, diagnosis, treatment and vaccines.
Officials are working on plans to intensify research on mRNA vaccines for cancer, bringing together learning gained through the pandemic, with expertise in cancer immunotherapy treatment.
In cancer, existing vaccines - such as the HPV jab - have largely been used to protect the body against viruses that cause cancers such as cervical disease.
But scientists have started trials of personalised vaccines which could be trained to recognise cancer cells - triggering an immune response should the disease return, which prevents its spread.
Mr Javid is expected to promise to boost the cancer workforce, in order to meet growing demand, as well as catch up with a backlog of cases which should have been diagnosed earlier.
Ministers have already promised that three in four cancers should be diagnosed at an early stage by 2028.
And health officials have promised to create 160 “faster diagnosis pathways” which aim to speed up diagnosis for cancer, and ensure fewer cases are missed.
Michelle Mitchell, Cancer Research UK’s chief executive, said: “For years, progress in cancer has been too slow – and due to the disruption of the pandemic, we now face the prospect of that progress stalling. As a country we should not be satisfied with the pace of change to date, or the fact that the burden of cancer weighs heaviest on the most deprived in the UK.
“The Secretary of State has set out a bold ambition for cancer services. We must make the most of this opportunity, going further and faster than we have before. And critically, this ambition must be backed with funding and accountability.
"It has been an incredibly difficult time for people affected by this disease. Now is the moment to work harder, and work together, for the millions of us in the UK affected by cancer.”
Front Page Newsletter
Your essential morning and evening briefing
Sign up
Related Topics
Vaccines, Cancer, NHS, Sajid Javid, Institute of Cancer Research
162
The Telegraph values your comments but kindly requests all posts are on topic, constructive and respectful. Please review our commenting policy.
Show comments
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
